Revenue | ₹741.98Cr |
Net Profits | ₹98.25Cr |
Net Profit Margins | 13.24% |
Marksans Pharma Ltd’s revenue jumped 15.6% since last year same period to ₹741.98Cr in the Q2 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated 18.6% jump in its revenue since last 3-months.
Marksans Pharma Ltd’s net profit jumped 1.58% since last year same period to ₹98.25Cr in the Q2 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated 68.47% jump in its net profits since last 3-months.
Marksans Pharma Ltd’s net profit margin fell -12.13% since last year same period to 13.24% in the Q2 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated 42.05% jumped in its net profit margins since last 3-months.
The revenue for Marksans Pharma Ltd in the Q2 results 2025 was ₹741.98Cr.
The net profit for Marksans Pharma Ltd in the Q2 results 2025 was ₹98.25Cr.
The net profit margin for Marksans Pharma Ltd in the Q2 results 2025 was 13.24%.
The revenue for Marksans Pharma Ltd in the Q2 results 2024 was ₹641.85Cr.
The net profit for Marksans Pharma Ltd in the Q2 results 2024 was ₹96.72Cr.
The net profit margin for Marksans Pharma Ltd in the Q2 results 2024 was 15.07%.